Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jbior.2021.100819 http://scihub22266oqcxt.onion/10.1016/j.jbior.2021.100819 34332403!8299150!34332403     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Adv+Biol+Regul 2021 ; 81 (ä): 100819 Nephropedia Template TP {{tp|p=34332403|t=2021. Thromboprophylaxis in COVID-19 - Rationale and considerations |pdf=|usr=}}{{34332403}} gab.com Text Thromboprophylaxis in COVID-19 - Rationale and considerations JO: Adv Biol Regul http://www.kidney.de/pget.php?&tw=1&pmid=34332403 #FOAvip The Corona Virus Disease-2019 (COVID-19) pandemic is associated with a very high incidence of thrombotic complications. The exact mechanisms for this excess risk for clots have not been elucidated although one of the often-quoted pathophysiological entity is immunothrombosis. Recognition of thrombotic complications early on in this pandemic led to an over-explosion of studies which looked at the benefits of anticoagulation to mitigate this risk. In this review, we examine the rationale for thromboprophylaxis in COVID-19 with particular reference to dosing and discuss what may guide the decision-making process to consider anticoagulation. In addition, we explore the rationale for thrombosis prevention measures in special populations including outpatient setting, pregnant females, children, those with high body mass index and those on extracorporeal membrane oxygenation. Twit Text FOAVip Thromboprophylaxis in COVID-19 - Rationale and considerations ????Adv Biol Regul http://www.kidney.de/pget.php?&tw=1&pmid=34332403 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34332403 #FOAvip English Wikipedia <ref>{{Cite pmid|34332403}}</ref> Thromboprophylaxis in COVID-19 - Rationale and considerations #MMPMID34332403 Bristogiannis S; Swan D; Thachil J Adv Biol Regul 2021[Aug]; 81 (ä): 100819 PMID34332403show ga The Corona Virus Disease-2019 (COVID-19) pandemic is associated with a very high incidence of thrombotic complications. The exact mechanisms for this excess risk for clots have not been elucidated although one of the often-quoted pathophysiological entity is immunothrombosis. Recognition of thrombotic complications early on in this pandemic led to an over-explosion of studies which looked at the benefits of anticoagulation to mitigate this risk. In this review, we examine the rationale for thromboprophylaxis in COVID-19 with particular reference to dosing and discuss what may guide the decision-making process to consider anticoagulation. In addition, we explore the rationale for thrombosis prevention measures in special populations including outpatient setting, pregnant females, children, those with high body mass index and those on extracorporeal membrane oxygenation. |*Extracorporeal Membrane Oxygenation[MESH] |*SARS-CoV-2[MESH] |Anticoagulants/*therapeutic use[MESH] |COVID-19/complications/epidemiology/*therapy[MESH] |Clinical Decision-Making[MESH] |Humans[MESH]Thromboprophylaxis in COVID-19 - Rationale and considerations (epmc).pdf DeepDyve Pubget Overpricing